1.Optimization of Preparation Technics for Liver-strengthening Cholagogue Oral Preparations by Orthogonal Test
Junxi WANG ; Wenqing SUN ; Yuanchao ZANG ; Xiaolimg LI ; Junyin ZHAO
China Pharmacy 2005;0(18):-
OBJECTIVE:To optimize the extraction technics of liver-strengthening cholagogue oral preparation.METHODS:The effects of the four factors-the quantity of the added water,the decoction time,the decoction times and the alcohol precipitation concentration on the extraction results were determined with content of total flavonoids taken as index.RESULTS:The best extracting condition was the following,the amount of the added water was 10 times that of the medicinal materials,the decoction duration was 60min,the alcohol precipitation concentration was 50%and the decoction was carried out twice.CONCLUSION:The preparation under this technics is of high clarity and stable contents.
2.Preparation of span-poly(ethylene glycol) ultrasound contrast agent microbubbles combined with folate-carbon nano tube-paclitaxel
Junxi LIU ; Jie ZHANG ; Yu ZHANG ; Yue ZHAO ; Guojing WAN ; Guozhong LI
Chinese Journal of Tissue Engineering Research 2017;21(2):260-267
BACKGROUND:As the sensitivity, clarity and accuracy of traditional ultrasound contrast agents are easy to be affected by objective factors, it is difficult to achieve diagnose and therapy simultaneously. Carbon nano tubes (CNTs) possess a specific reticular, hol ow and tubular structure and the potential to enhance the ultrasound imaging. The functional CNTs obtained through non-covalent adsorption, covalent bonding and internal embedding hold a good biocompatibility and high drug loading efficiency. So the drug loaded CNTs are added into the microbubble to synthesize a multi-functional ultrasound contrast agent. OBJECTIVE:To prepare the span-poly(ethylene glycol) (span-PEG) ultrasound contrast agent microbubble combined with folate-CNTs-paclitaxel (FA-CNTs-PTX) and to investigate its appearance, particle size as wel as loading efficiency of CNTs and PTX. METHODS:Firstly, the span-PEG microbubble was prepared using the acoustic cavitation method and its preparation process was optimized through the orthogonal experiment. Then the FA-CNTs-PTX compound was synthesized by the electrostatic self-assembly andπ-πadsorption principle. In the end, the span-PEG ultrasound contrast agent microbubble combined with FA-CNTs-PTX was obtained by loading the FA-CNTs-PTX into the span-PEG microbubble. The appearance of the composite microbubble were observed using scanning and transmission electron microscopes, the distribution and average particle size were detected by laser particle size analyzer, and the loading efficiency of CNTs and PTX was measured through ultraviolet spectroscopy. RESULTS AND CONCLUSION:The composite microbubble had a smooth surface and the average particle size was 442 nm. The loading efficiency of CNTs and PTX in the composite microbubble was 1.69%and 47.9%, respectively. To conclude, the FA-CNTs-PTX targeting drug delivery system is successful y loaded into the span-PEG microbubble. The composite microbubble is a hol ow sphere that has uniform nanoscaled particle size distributions, which is expected to become an ideal ultrasound contrast agent involved in angiography and targeting therapy.
3.A multi-modal image registration method for use in thermotherapy of tumor.
Yongming ZHAO ; Changyan XIAO ; Junxi SUN ; Jingfeng BAI ; Yazhu CHEN
Journal of Biomedical Engineering 2004;21(6):935-938
In the interactive image-guided thermotherapy, we need the real time image and location of the target tumor. But the current mono-modal imaging technique can not do it. We present a method to register a preoperative 3D MRI volume to a set of intra-operative ultrasound images for the target localization of the liver tumor in the thermotherapy. The registration method is a genetic algorithm based on the features such as liver surface vessels and liver surface.
Humans
;
Hyperthermia, Induced
;
Image Processing, Computer-Assisted
;
Imaging, Three-Dimensional
;
Liver Neoplasms
;
diagnostic imaging
;
therapy
;
Magnetic Resonance Imaging
;
Ultrasonic Therapy
;
methods
;
Ultrasonography, Interventional
4.Meta-analysis of the effect of Xuebijing injection on lactic acid clearance in sepsis
Junxi LIU ; Caijun WU ; Yiyuanzi ZHAO ; Wei BI
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2024;31(2):134-140
Objective To systematically evaluate the effect of Xuebijing injection on lactic acid clearance in sepsis,and to provide the theoretical basis for the application of Xuebijing injection in the field of lactic acid clearance in sepsis.Methods Randomized controlled trials(RCT)of the effect of Xuebijing injection on lactic acid clearance in sepsis were retrieved in Chinese and English databases,including China National Knowledge Internet(CNKI),Wanfang Database,VIP Database,Chinese Biomedical Database(CBM),PubMed,Embase,Cochrane Library Database,and Web of Science.These trials were evaluated according to the Cochrane Handbook 5.1.0 standard and analyzed using RevMan 5.4 software for Meta-analysis.Funnel plots were used to assess publication bias in the included studies Results A total of 13 articles with 872 patients were included,including 446 patients in the experimental group(Xuebijing injection and conventional treatment group)and 426 patients in the control group(conventional treatment group).Meta-analysis showed that the blood lactic acid concentrations at 12 hours and 24 hours in the experimental group were lower than those of the control group[mean difference(MD)=-0.88,-0.73;95%confidence interval(95%CI)were-1.26 to-0.50,-0.89 to-0.57;P<0.000 1)].The experimental group exhibited a better 24 hours lactic acid clearance rate(MD=17.20,95%CI was 8.80 to 25.59;P<0.000 1),and a reduced sequential organ failure assessment(SOFA)score(MD=-2.41,95%CIwas-2.79 to-2.03,P<0.00001).Additionally,the experimental group demonstrated lower 28-day mortality rates compared to the control group[odds ratio(OR)=0.51,95%CI was 0.30-0.88,P=0.02];the differences were all statistically significant.Conclusion Xuebijing injection benefits by enhancing the lactic acid clearance capacity of sepsis patients,thereby alleviating the sepsis condition and improve improving the prognosis.
5.The correlation between the ratio of C-reactive protein to albumin and Wei-Qi-Ying-Xue syndrome in patients with severe COVID-19
Lan LI ; Caijun WU ; Linqin MA ; Yuanzhen JIAN ; Jiahui SU ; Junxi LIU ; Yiyuanzi ZHAO
Journal of Chinese Physician 2024;26(2):172-175
Objective:To explore the correlation between the ratio of C-reactive protein (CRP) to albumin (CAR) and the syndrome type of Wei-Qi-Ying-Xue in patients with severe coronavirus disease 2019 (COVID-19).Methods:A case-control study was conducted to select 63 severe patients with COVID-19 admitted to the Dongzhimen Hospital of Beijing University of Chinese Medicine from December 2022 to December 2023, including 50 severe cases and 13 critical cases. The clinical data of the patients were collected. According to the syndrome differentiation of Wei-Qi-Ying-Xue, there were 21 cases of Qi syndrome, 20 cases of Ying syndrome and 22 cases of Xue syndrome. The differences of CRP, ALB and CAR levels in patients with different Wei-Qi-Ying-Xue syndromes were compared. Spearman correlation test was used to test the correlation between CRP, ALB, CAR and the Wei-Qi-Ying-Xue syndrome type, and the receiver operating characteristic (ROC) curve was used to detect the diagnostic efficacy of CRP, ALB and CAR on the Wei-Qi-Ying-Xue syndrome type.Results:There was a statistically significant difference in the clinical classification of Western medicine among the three groups ( P<0.05). The CAR of the Ying group and the Xue group was higher than that of the Qi group ( P<0.05), while there was no statistically significant difference in age and comorbidities (all P>0.05). The CRP of the Xue group was higher than that of the Qi group ( P<0.05), and the ALB of the Ying group and the Xue group was lower than that of the Qi group (all P<0.05). Correlation analysis showed that there was a correlation between the Wei-Qi-Ying-Xue syndrome type and CRP, ALB and CAR ( P<0.05), among which CAR changed most significantly with the change of Wei-Qi-Ying-Xue syndrome type. ROC curve analysis showed that CRP, ALB and CAR had good diagnostic value for Qi syndrome and Xue syndrome ( P<0.05). The critical values of the diagnosis of Qi syndrome were 48.57 mg/L, 34.20 g/L and 2.97. The critical values of the diagnosis of Xue syndrome were 28.30 mg/L, 26.6 g/L and 5.96. Conclusions:CAR ratio is correlated with the Wei-Qi-Ying-Xue syndrome type of severe COVID-19 patients, and its level changes are in line with the evolution law of Wei-Qi-Ying-Xue syndrome. CAR≤2.97 is contributed to the diagnosis of Qi syndrome, and CAR>5.96 is contributed to the diagnosis of Xue syndrome. CAR may be an objective index related to the Wei-Qi-Ying-Xue syndrome type of severe COVID-19 patients.
6.Prediction Study on Suitable Growth Areas of Polygala tenuifolia in Shanxi Province Based on MaxEnt Model and ArcGIS
Xia JIANG ; Yuerong ZHANG ; Junxi ZHAO ; Panpan SHI ; Haixian ZHAN
Chinese Journal of Information on Traditional Chinese Medicine 2024;31(7):1-7
Objective To predict the potential suitable distribution areas of Polygala tenuifolia in Shanxi Province;To provide basis for the excavation and utilization of existing resources and the selection of cultivation areas of Polygala tenuifolia.Methods The distribution information of 1 102 Polygona tenuifolia samples was collected(Among them,there were 1 060 samples of Polygala tenuifolia Willd.,42 samples of Polygala sibirica L.).Combined with the 55 ecological factor data,the MaxEnt model and ArcGIS were applied to analyze the main ecological factors affecting the distribution of Polygala tenuifolia.Results The dominant ecological factors for the suitability distribution of Polygala tenuifolia were vegetation type,precipitation,temperature,etc.The potential suitable distribution areas of Polygala tenuifolia in Shanxi Province were mainly concentrated in Linfen,Lvliang,Taiyuan,Changzhi,Jinzhong,southeastern of Yuncheng,northwestern of Xinzhou,southwestern of Shuozhou,etc.Conclusion The ecological suitability zoning map of Polygala tenuifolia Willd.and Polygala sibirica L.was obtained,which can provide reference for the reasonable selection of planting areas and standardized production of Polygala tenuifolia in Shanxi Province.
7.Study on Regionalization of Wild Ziziphus jujuba var.spinosa in Shanxi Province
Junxi ZHAO ; Yuerong ZHANG ; Xia JIANG ; Panpan SHI ; Haixian ZHAN ; Chenhui DU
Chinese Journal of Information on Traditional Chinese Medicine 2024;31(8):6-11
Objective To establish the distribution zoning of Ziziphus jujuba var.spinosa in Shanxi Province;To help the development of Z.jujuba var.spinosa industry in Shanxi Province.Methods Combined with the information of longitude and latitude of sample points from the forth national survey resources and environment factors data in Grid Database of Spatial Information of TCM Resources,the MaxEnt model and ArcGIS were applied to analyze the main environmental factors affecting the suitability distribution of Z.jujuba var.spinosa.Results Dominant ecological factors for the suitability distribution of Z.Jujuba var.spinosa were vegetation type,lowest temperature of coldest month,monthly precipitation in November,monthly precipitation in October,altitude,and slope.The reclassified suitability grid data of ArcGIS software showed that Z.jujuba var.spinosa suitability distribution area including 0.73×104 km2 of high suitability area,1.41×104 km2 of medium suitability area and 4.33×104 km2 of low suitability area.The potential suitable distribution areas of Z.jujuba var.spinosa were mainly concentrated in the central and southern Shanxi Province.Conclusion This study shows that the most suitable growth area of Z.jujuba var.spinosa is mainly located in central and southern Shanxi Province,which can provide reference for the development,utilization and standardized planting of wild resources of Z.jujuba var.spinosa.
8.Clinical efficacy of Atezolizumab and Bevacizumab in the treatment of initially borderline resectable advanced liver cancer
Bowen YAO ; Junxi XIANG ; Xin ZHENG ; Hao SUN ; Wei YANG ; Yuelang ZHANG ; Feng YE ; Dongli ZHAO ; Yingmin YAO ; Qingguang LIU ; Cheng GUO
Chinese Journal of Digestive Surgery 2022;21(2):303-306
Conversion therapy has become the core in the treatment of borderline resectable or unresectable liver cancer, which provides resectable opportunities for more advanced liver cancer patients. In accordance with the first-choice treatment regimen recommended by the guidelines, the authors reported a successful case of Atezolizumab and Bevacizumab (T+A regimen) conversion therapy. The patient with initially borderline resectable advanced liver cancer was performed liver segment resection sucessfully after conversion therapy, and non-tumor recurrence was observed at postoperative 9 months. Postoperative pathological examination showed combined hepatocellular-cholangiocarcinoma, which also indicated the important value of T+A regimen in the conversion therapy of combined hepatocellular-cholangiocarcinoma.
9.Study on pharmacokinetics and tissue distribution of the isocorydine derivative (AICD) in rats by HPLC-DAD method.
Yali CHEN ; Qian YAN ; Mei ZHONG ; Quanyi ZHAO ; Junxi LIU ; Duolong DI ; Jinxia LIU
Acta Pharmaceutica Sinica B 2015;5(3):238-245
A simple and effective high-performance liquid chromatography with diode-array detection method coupled with a liquid-liquid extraction pretreatment has been developed for determining the pharmacokinetics and tissue distribution of a novel structurally modified derivative (8-acetamino-isocorydine) of isocorydine. According to the in vivo experiments data calculations by DAS 2.0 software, a two-compartment metabolic model was suitable for describing the pharmacokinetic of 8-acetamino-isocorydine in rats. 8-Acetamino-isocorydine was absorbed well after oral administration, and the absolute bioavailability was 76.5%. The half-life of 8-acetamino-isocorydine after intravenous and oral administration was 2.2 h and 2.0 h, respectively. In vivo, 8-acetamino-isocorydine was highly distributed in the lungs, kidney and liver; however, relatively little entered the brain, suggesting that 8-acetamino-isocorydine could not easily pass through the blood brain barrier. Our work describes the first characterization of the pharmacokinetic parameters and tissue distribution of 8-acetamino-isocorydine. The acquired data will provide useful information for the in vivo pharmacology of 8-acetamino-isocorydine, and can be applied to new drug research.